Skip to main content
Journal cover image

Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study.

Publication ,  Journal Article
Jeong, Y-H; Abadilla, KA; Tantry, US; Park, Y; Koh, J-S; Kwak, CH; Hwang, J-Y; Gurbel, PA
Published in: J Thromb Haemost
June 2013

Duke Scholars

Published In

J Thromb Haemost

DOI

EISSN

1538-7836

Publication Date

June 2013

Volume

11

Issue

6

Start / End Page

1194 / 1197

Location

England

Related Subject Headings

  • Ticlopidine
  • Polymorphism, Single Nucleotide
  • Platelet Function Tests
  • Platelet Aggregation Inhibitors
  • Pilot Projects
  • Pharmacogenetics
  • Percutaneous Coronary Intervention
  • Odds Ratio
  • Multivariate Analysis
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jeong, Y.-H., Abadilla, K. A., Tantry, U. S., Park, Y., Koh, J.-S., Kwak, C. H., … Gurbel, P. A. (2013). Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study. J Thromb Haemost, 11(6), 1194–1197. https://doi.org/10.1111/jth.12200
Jeong, Y. -. H., K. A. Abadilla, U. S. Tantry, Y. Park, J. -. S. Koh, C. H. Kwak, J. -. Y. Hwang, and P. A. Gurbel. “Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study.J Thromb Haemost 11, no. 6 (June 2013): 1194–97. https://doi.org/10.1111/jth.12200.
Journal cover image

Published In

J Thromb Haemost

DOI

EISSN

1538-7836

Publication Date

June 2013

Volume

11

Issue

6

Start / End Page

1194 / 1197

Location

England

Related Subject Headings

  • Ticlopidine
  • Polymorphism, Single Nucleotide
  • Platelet Function Tests
  • Platelet Aggregation Inhibitors
  • Pilot Projects
  • Pharmacogenetics
  • Percutaneous Coronary Intervention
  • Odds Ratio
  • Multivariate Analysis
  • Middle Aged